| By PR Newswire |
Article Rating: |
|
| January 17, 2013 03:01 PM EST |
Reads: |
113 |
NATICK, Mass., Jan. 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and full year ended December 31st, 2012 on Tuesday, January 29th, at 8:00 a.m. ET.
The call will be hosted by Michael Mahoney, president and chief executive officer, and Jeff Capello, executive vice president and chief financial officer.
A live webcast of the conference call will be available via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
The webcast is also being distributed over Thomson Reuters Investor Distribution Network via two locations: www.earnings.com, which is accessible to the public, and www.streetevents.com, a password-protected event management site.
An archived replay of the webcast will be accessible at www.bostonscientific.com/investors approximately one hour following the completion of the conference call and available for approximately one year.
The company will issue a press release announcing financial results for the fourth quarter and full year 2012 on Tuesday, January 29th, prior to the conference call.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit us at www.bostonscientific.com.
CONTACT:
Steven Campanini
508-652-5740 (office)
Media Relations
Boston Scientific Corporation
media@bsci.com
Michael Campbell
508-650-8023 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com
SOURCE Boston Scientific Corporation
